The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic utility of a personalized ctDNA minimal residual disease test in patients undergoing curative resection of HPV-negative head and neck squamous cell carcinoma.
 
Natalya Karasik
No Relationships to Disclose
 
Jacob Miller
No Relationships to Disclose
 
Chandana Reddy
No Relationships to Disclose
 
Shauna Campbell
No Relationships to Disclose
 
Kyunghee Burkitt
No Relationships to Disclose
 
Tamara Sussman
Research Funding - Bicara Therapeutics; Privo Technologies
 
Eric Lamarre
No Relationships to Disclose
 
Brandon Prendes
No Relationships to Disclose
 
Jamie Ku
Consulting or Advisory Role - EMD Serono
 
Natalie Silver
No Relationships to Disclose
 
Joseph Scharpf
No Relationships to Disclose
 
Jessica Geiger
Consulting or Advisory Role - Astellas Pharma; AVEO; EMD Serono
Research Funding - Alkermes (Inst); Genentech/Roche (Inst); Merck (Inst); Merck Serono (Inst); Merck Serono (Inst); Regeneron (Inst)
 
Danielle Bottalico
No Relationships to Disclose
 
Timothy Chan
Leadership - Bristol-Myers Squibb; Cancer Genetics; Illumina
Stock and Other Ownership Interests - Gritstone Bio
Honoraria - Illumina
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Illumina; LG Chem; Pfizer
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Nysnobio (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Neoantigen discovery and genomic biomarkers for immunotherapy response
 
Shlomo Koyfman
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Galera Therapeutics; Merck Sharp & Dohme; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Merck Sharp & Dohme (Inst)
Other Relationship - UpToDate
 
Neil Woody
No Relationships to Disclose